1. Home
  2. PTCT vs MYRG Comparison

PTCT vs MYRG Comparison

Compare PTCT & MYRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

SELL

Current Price

$63.51

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Logo MYR Group Inc.

MYRG

MYR Group Inc.

SELL

Current Price

$312.61

Market Cap

4.9B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
PTCT
MYRG
Founded
1998
1891
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Water Sewer Pipeline Comm & Power Line Construction
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.9B
IPO Year
2006
2008

Fundamental Metrics

Financial Performance
Metric
PTCT
MYRG
Price
$63.51
$312.61
Analyst Decision
Buy
Buy
Analyst Count
14
7
Target Price
$101.07
★ $400.20
AVG Volume (30 Days)
★ 1.2M
226.2K
Earning Date
11-03-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
264.48
★ 311.48
EPS
0.90
★ 6.15
Revenue
$264,734,000.00
★ $1,531,169,000.00
Revenue This Year
N/A
$19.98
Revenue Next Year
$9.26
$15.47
P/E Ratio
$71.38
★ $50.66
Revenue Growth
★ 36.19
N/A
52 Week Low
$61.23
$190.14
52 Week High
$90.87
$503.57

Technical Indicators

Market Signals
Indicator
PTCT
MYRG
Relative Strength Index (RSI) 40.49 57.69
Support Level $62.46 $251.81
Resistance Level $72.86 $350.33
Average True Range (ATR) 2.00 11.16
MACD 0.19 4.02
Stochastic Oscillator 38.57 65.64

Price Performance

Historical Comparison
PTCT
MYRG

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About MYRG MYR Group Inc.

MYR Group Inc is a U.S. based holding company of specialty electrical construction service providers. Through its subsidiaries, it serves electric utility, commercial, and industrial construction markets in the United States and Canada, offering services such as design, engineering, procurement, construction, upgrades, maintenance, and repair, with a focus on construction, maintenance, and repair work. The company operates through two segments: Transmission and Distribution (T&D) and Commercial and Industrial (C&I). The majority of revenue is derived from the T&D segment, which provides a range of services on electric transmission and distribution networks and substation facilities, which include design, engineering, procurement, construction, upgrade and maintenance and repair services.

Share on Social Networks: